🔗 Visit the ClinicalTrials.gov page for NCT02780752
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | 4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer. | Front Immunol | 2015 | 0.95 |
| 2 | Inhibition of hyaluronan synthesis restores immune tolerance during autoimmune insulitis. | J Clin Invest | 2015 | 0.82 |